Nexalin Technology, based in Irvine, California, designs and manufactures FDA-cleared transcranial electrical stimulation equipment that provides a non-invasive and drug-free therapy for anxiety, depression, and insomnia. The company's patented waveform produces Transcranial Electrical Stimulation (TES), which affects the hypothalamus and related brain structures to normalize neurochemistry. This therapy is long-lasting and has undergone extensive safety analysis, making it a low-risk device for clinical trials. Nexalin's treatments allow patients to avoid medication side effects and experience improvements in their conditions after completing sessions.